Background: Optimal blood pressure (BP) management after intraarterial thrombectomy (IAT) has yet to be thoroughly elucidated. We assessed whether maintaining a systolic BP (SBP) of ≤130 mm Hg for 24 h following IAT was associated with better outcomes in patients with successful recanalization. Methods: Patients presenting with large vessel occlusion within 4 h from symptom onset underwent IAT based on multiphase computed tomography angiography, and those achieving successful recanalization were included in this retrospective analysis. Patients were dichotomized based on a 24-h mean SBP after IAT >130 or ≤130 mm Hg, and functional outcomes were compared at 3 months. At 3 months, 24-h mean SBPs were compared based on recanalization degree, baseline collateral status, stroke mechanism, and occlusion site. Results: The proportion of favorable outcomes at 3 months (modified Rankin Scale [mRS] 0–2) was significantly lower in patients with a mean SBP >130 mm Hg over the 24 h after IAT (40.5 vs. 66.7%, p = 0.02). The distribution of mRS varied significantly among patients with complete recanalization, poor baseline collateral status (pial arterial filling score 0–3), cardioembolic stroke, or middle cerebral artery occlusion, with higher mRS values associated with higher mean SBPs. A mean SBP >130 mm Hg during the 24 h after IAT was associated with worse functional outcomes after multivariable adjustment (OR 2.66; 95% CI 1.11–6.41; p= 0.03). Conclusion: Stricter BP control during the 24 h following IAT may improve clinical outcomes in patients with large vessel occlusion who achieved successful recanalization.

Keywords:
Stroke, Endovascular recanalization, Thrombectomy, Blood pressure, Treatment outcome
1.
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al.; American Heart Association Stroke Council. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.
Stroke
. 2018 Mar;49(3):e46–110.
2.
Ahmed N, Wahlgren N, Brainin M, Castillo J, Ford GA, Kaste M, et al.; SITS Investigators. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR).
Stroke
. 2009 Jul;40(7):2442–9.
3.
Anderson CS, Huang Y, Lindley RI, Chen X, Arima H, Chen G, et al.; ENCHANTED Investigators and Coordinators. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
Lancet
. 2019 Mar;393(10174):877–88.
4.
Mistry EA, Mistry AM, Nakawah MO, Khattar NK, Fortuny EM, Cruz AS, et al. Systolic Blood Pressure Within 24 Hours After Thrombectomy for Acute Ischemic Stroke Correlates With Outcome.
J Am Heart Assoc
. 2017 May;6(5):6.
5.
Goyal N, Tsivgoulis G, Pandhi A, Chang JJ, Dillard K, Ishfaq MF, et al. Blood pressure levels post mechanical thrombectomy and outcomes in large vessel occlusion strokes.
Neurology
. 2017 Aug;89(6):540–7.
6.
Chang JY, Jeon SB, Jung C, Gwak DS, Han MK. Postreperfusion Blood Pressure Variability After Endovascular Thrombectomy Affects Outcomes in Acute Ischemic Stroke Patients With Poor Collateral Circulation.
Front Neurol
. 2019 Apr;10:346.
7.
Menon BK, d’Esterre CD, Qazi EM, Almekhlafi M, Hahn L, Demchuk AM, et al. Multiphase CT Angiography: A New Tool for the Imaging Triage of Patients with Acute Ischemic Stroke.
Radiology
. 2015 May;275(2):510–20.
8.
Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al.; Second European-Australasian Acute Stroke Study Investigators. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II).
Lancet
. 1998 Oct;352(9136):1245–51.
9.
De’ath G, Fabricius KE. Classification and regression trees: A powerful yet simple technique for ecological data analysis.
Ecology
. 2000;81(11):3178–92.
10.
Sharma VK. Elevated Blood Pressure in Acute Ischemic Stroke–treat or Leave?
Cerebrovasc Dis
. 2016;41(3-4):101–2.
11.
Tarlov N, Nien YL, Zaidat OO, Nguyen TN. Periprocedural management of acute ischemic stroke intervention.
Neurology
. 2012 Sep;79(13 Suppl 1):S182–91.
12.
Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, et al.; HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.
Lancet
. 2016 Apr;387(10029):1723–31.
13.
Jadhav AP, Molyneaux BJ, Hill MD, Jovin TG. Care of the Post-Thrombectomy Patient.
Stroke
. 2018 Nov;49(11):2801–7.
14.
Nour M, Scalzo F, Liebeskind DS. Ischemia-reperfusion injury in stroke.
Intervent Neurol
. 2013 Sep;1(3-4):185–99.
15.
Fagan SC, Bowes MP, Lyden PD, Zivin JA. Acute hypertension promotes hemorrhagic transformation in a rabbit embolic stroke model: effect of labetalol.
Exp Neurol
. 1998 Mar;150(1):153–8.
16.
Appleton JP, Sprigg N, Bath PM. Blood pressure management in acute stroke.
Stroke Vasc Neurol
. 2016 Jun;1(2):72–82.
17.
Stead LG, Gilmore RM, Vedula KC, Weaver AL, Decker WW, Brown RD Jr. Impact of acute blood pressure variability on ischemic stroke outcome.
Neurology
. 2006 Jun;66(12):1878–81.
18.
Bang OY, Goyal M, Liebeskind DS. Collateral Circulation in Ischemic Stroke: Assessment Tools and Therapeutic Strategies.
Stroke
. 2015 Nov;46(11):3302–9.
19.
Seyman E, Shaim H, Shenhar-Tsarfaty S, Jonash-Kimchi T, Bornstein NM, Hallevi H. The collateral circulation determines cortical infarct volume in anterior circulation ischemic stroke.
BMC Neurol
. 2016 Oct;16(1):206.
20.
Marks MP, Lansberg MG, Mlynash M, Olivot JM, Straka M, Kemp S, et al.; Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution 2 Investigators. Effect of collateral blood flow on patients undergoing endovascular therapy for acute ischemic stroke.
Stroke
. 2014 Apr;45(4):1035–9.
21.
Marsh EB, Llinas RH, Hillis AE, Gottesman RF. Hemorrhagic transformation in patients with acute ischaemic stroke and an indication for anticoagulation.
Eur J Neurol
. 2013 Jun;20(6):962–7.
22.
Marsh EB, Llinas RH, Schneider AL, Hillis AE, Lawrence E, Dziedzic P, et al. Predicting Hemorrhagic Transformation of Acute Ischemic Stroke: Prospective Validation of the HeRS Score.
Medicine (Baltimore)
. 2016 Jan;95(2):e2430.
23.
Rebello LC, Bouslama M, Haussen DC, -Dehkharghani S, Grossberg JA, Belagaje S, et al. Endovascular Treatment for Patients With Acute Stroke Who Have a Large Ischemic Core and Large Mismatch Imaging Profile.
JAMA Neurol
. 2017 Jan;74(1):34–40.
24.
Campbell BC, Majoie CB, Albers GW, Menon BK, Yassi N, Sharma G, et al.; HERMES collaborators. Penumbral imaging and -functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data.
Lancet Neurol
. 2019 Jan;18(1):46–55.
25.
Chang JY, Jeon SB, Lee JH, Kwon OK, Han MK. The Relationship between Blood -Pressure Variability, Recanalization Degree, and Clinical Outcome in Large Vessel Occlusive Stroke after an Intra-Arterial Thrombectomy.
Cerebrovasc Dis
. 2018;46(5-6):279–86.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.